Research

Since our inception in 1994, our goal has been to create a comprehensive and dedicated network of patients, researchers and health care professionals focused on providing excellent care to individuals diagnosed with the rare neuroimmune disorders of the central nervous system, including acute disseminated encephalomyelitis (ADEM), acute flaccid myelitis (AFM), MOG antibody disease, neuromyelitis optica spectrum disorder (NMOSD), optic neuritis (ON) and transverse myelitis (TM); while advancing our understanding of the causes and the natural history of these diseases to develop new acute and restorative therapies.